Cargando…

Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis

Hydrogen sulfide (H(2)S) is a gasotransmitter which regulates multiple cardiovascular functions. However, the precise roles of H(2)S in modulating myocardial fibrosis in vivo and cardiac fibroblast proliferation in vitro remain unclear. We investigated the effect of GYY4137, a slow-releasing H(2)S d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Guoliang, Zhu, Jinbiao, Xiao, Yujiao, Huang, Zhengrong, Zhang, Yuqing, Tang, Xin, Xie, Liping, Chen, Yu, Shao, Yongfeng, Ferro, Albert, Wang, Rui, Moore, Philip K., Ji, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442292/ https://www.ncbi.nlm.nih.gov/pubmed/26078813 http://dx.doi.org/10.1155/2015/691070

Ejemplares similares

Synthesis of Sulfur-35-Labeled Trisulfides and GYY-4137 as Donors of Radioactive Hydrogen Sulfide
por: Brown, Eric M., et al.
Publicado: (2023)

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo
por: Lee, Zheng Wei, et al.
Publicado: (2011)

Hydrogen Sulfide Donor GYY4137 Rescues NRF2 Activation in Respiratory Syncytial Virus Infection
por: de Mello, Aline Haas, et al.
Publicado: (2022)

GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats
por: Meng, Guoliang, et al.
Publicado: (2015)

GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney
por: John, AM Sashi Papu, et al.
Publicado: (2017)

The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells
por: Li, Ling, et al.
Publicado: (2013)

Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H(2)S-Producing Enzymes in Multiple Sclerosis
por: Lazarević, Milica, et al.
Publicado: (2020)

Improved growth of pea, lettuce, and radish plants using the slow release of hydrogen sulfide from GYY-4137
por: Carter, Justin M., et al.
Publicado: (2018)

GYY4137-Derived Hydrogen Sulfide Donates Electrons to the Mitochondrial Electron Transport Chain via Sulfide: Quinone Oxidoreductase in Endothelial Cells
por: Star, Bastiaan S., et al.
Publicado: (2023)

A H(2)S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice
por: Liu, Mi, et al.
Publicado: (2016)

Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death
por: Sakuma, Satoru, et al.
Publicado: (2019)

GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K(V)7 Channel Blockers in Rat Small Mesenteric Arteries
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H(2)S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization
por: Berenyiova, Andrea, et al.
Publicado: (2022)

Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis
por: Xu, Zhong-Shi, et al.
Publicado: (2018)

The protective effects of GYY4137 on ipsilateral testicular injury in experimentally varicocele-induced rats
por: Ning, Jin-Zhuo, et al.
Publicado: (2018)

The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain
por: Bai, Xue, et al.
Publicado: (2021)

GYY4137, an H(2)S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease
por: Hou, Xiaoou, et al.
Publicado: (2017)

GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo
por: Chen, Zeyang, et al.
Publicado: (2019)

GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation
por: Zhou, Jun, et al.
Publicado: (2018)

GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling
por: Juin, Subir Kumar, et al.
Publicado: (2021)

TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis
por: Bátai, István Z., et al.
Publicado: (2019)

Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion from hepatocytes and is mitigated by GYY4137
por: Unuma, Kana, et al.
Publicado: (2019)

The H(2)S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
por: Lazarević, Milica, et al.
Publicado: (2018)

The H(2)S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H(2)S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
por: Van Dingenen, Jonas, et al.
Publicado: (2019)

GYY4137 a H(2)S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway
por: Xia, Yu-qi, et al.
Publicado: (2019)

A New Slow Releasing, H(2)S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium
por: Robinson, Hayley, et al.
Publicado: (2012)

Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
por: Zaorska, Ewelina, et al.
Publicado: (2020)

Hydrogen Sulfide Regulates Krüppel‐Like Factor 5 Transcription Activity via Specificity Protein 1 S‐Sulfhydration at Cys664 to Prevent Myocardial Hypertrophy
por: Meng, Guoliang, et al.
Publicado: (2016)

Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis
por: Kang, Se Chan, et al.
Publicado: (2020)

Roles of Hydrogen Sulfide Donors in Common Kidney Diseases
por: Ngowi, Ebenezeri Erasto, et al.
Publicado: (2020)

Role of hydrogen sulfide donors in cancer development and progression
por: Ngowi, Ebenezeri Erasto, et al.
Publicado: (2021)

Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy
por: Liang, Biao, et al.
Publicado: (2017)

Role of Hydrogen Sulfide in the Treatment of Fibrosis
por: Chirindoth, Swathy S, et al.
Publicado: (2021)

Characterization of the Inducible and Slow-Releasing Hydrogen Sulfide and Persulfide Donor P*: Insights into Hydrogen Sulfide Signaling
por: Trummer, Modesta, et al.
Publicado: (2021)

The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases
por: Wang, Yi-Zhen, et al.
Publicado: (2021)

Involvement of hydrogen sulfide in the progression of renal fibrosis
por: Wang, Yu, et al.
Publicado: (2019)

Function of gaseous hydrogen sulfide in liver fibrosis
por: Lee, Jae-Ho, et al.
Publicado: (2022)

Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway
por: Liu, Maojun, et al.
Publicado: (2018)

A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury
por: Sun, Xiaotian, et al.
Publicado: (2017)

Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy
por: Song, Kai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2sg7nq6a4am1hbq5842u4oegsn